JP2003096015A - Cyclic liquid crystalline composition - Google Patents

Cyclic liquid crystalline composition

Info

Publication number
JP2003096015A
JP2003096015A JP2001289723A JP2001289723A JP2003096015A JP 2003096015 A JP2003096015 A JP 2003096015A JP 2001289723 A JP2001289723 A JP 2001289723A JP 2001289723 A JP2001289723 A JP 2001289723A JP 2003096015 A JP2003096015 A JP 2003096015A
Authority
JP
Japan
Prior art keywords
liquid crystal
liquid crystalline
compound
liquid
calixarene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001289723A
Other languages
Japanese (ja)
Other versions
JP3849009B2 (en
Inventor
Hiroshi Shimizu
洋 清水
Takuji Sugino
卓司 杉野
Hirotatsu Monobe
浩達 物部
Helen Jarvis
ヘレン ジャービス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Priority to JP2001289723A priority Critical patent/JP3849009B2/en
Publication of JP2003096015A publication Critical patent/JP2003096015A/en
Application granted granted Critical
Publication of JP3849009B2 publication Critical patent/JP3849009B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a new cyclic liquid crystalline composition for an ionic conductive material. SOLUTION: The new cyclic liquid crystalline compound having a calixarene within its molecular core and a cone shape molecule shown by the formula below (wherein, R is Cn H2n+1 ; and n is an integer of 5 to 23) is provided.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、サーモトロピック
液晶性及びリオトロピック液晶性を兼ね備える新規な液
晶材料並びにチューブ状カラムナー液晶相の発現による
イオン伝導体に向け新規な液晶性化合物として合成され
た新規カリックスアレーン誘導体に関する。
TECHNICAL FIELD The present invention relates to a novel liquid crystal material having both thermotropic liquid crystallinity and lyotropic liquid crystallinity, and a novel calix synthesized as a novel liquid crystalline compound toward an ionic conductor by manifesting a tubular columnar liquid crystal phase. It relates to arene derivatives.

【0002】[0002]

【従来の技術と発明が解決しようとする課題】本発明
は、サーモトロピック液晶性及びリオトロピック液晶性
を兼ね備える新規な液晶材料並びにチューブ状カラムナ
ー液晶相の発現によるイオン伝導体に向けた新規な環状
液晶性組成物を提供することを目的とする。
DISCLOSURE OF THE INVENTION The present invention relates to a novel liquid crystal material having both thermotropic liquid crystallinity and lyotropic liquid crystallinity, and a novel ring-shaped liquid crystal for an ion conductor due to manifestation of a tubular columnar liquid crystal phase. It aims at providing a sex composition.

【0003】従来、様々な環の大きさを持つカリックス
アレーンが合成されてきたが、これは環の大きさによっ
て捕捉する金属イオンの選択性を出すためであった。ま
た、これらの金属イオン認識は、溶液中においてなされ
ることが証明されてきた。
Conventionally, calixarene having various ring sizes has been synthesized, but this is because the selectivity of the metal ion to be captured is obtained depending on the ring size. It has also been proved that these metal ion recognitions are made in solution.

【0004】しかし、これらの選択的金属イオンの認識
及び取り込み機能をイオン輸送という観点から見た場
合、カリックスアレーンが凝集して何らかの金属イオン
輸送の道筋を構築することが必要不可欠である。そのた
めに、カリックスアレーンを構造中心に持つ液晶性化合
物を合成しようとする試みが現在まで続けられている。
However, from the viewpoint of ion transport, the functions of recognizing and incorporating these selective metal ions are indispensable for the calixarene to aggregate to construct a route for metal ion transport. For that reason, attempts to synthesize liquid crystalline compounds having a calixarene in the center of the structure have been continued until now.

【0005】さらに、カリックスアレーンを分子骨格に
持つ液晶については幾つか公知の例が知られているが、
それらはいずれもサーモトロピック液晶性を有するもの
であり、リオトロピック液晶性も同時に有する化合物は
今までに見出されなかった。イオン伝導体への応用を考
えると、液晶状態の大きな分子運動は有利であり、かつ
分子の配向に伴ってイオンの動きやすい方向が決まるの
で好都合であるばかりか、溶剤など液体中で液晶相を示
すリオトロピック性はイオンの存在にも好都合となる。
Further, some known examples of liquid crystals having a calixarene in the molecular skeleton are known.
All of them have thermotropic liquid crystallinity, and no compound having lyotropic liquid crystallinity at the same time has been found. Considering the application to an ionic conductor, not only is large molecular motion in the liquid crystal state advantageous, and the direction in which the ions easily move is determined according to the orientation of the molecule, which is convenient, and the liquid crystal phase in a liquid such as a solvent The lyotropic properties exhibited also favor the presence of ions.

【0006】従って、カリックスアレーンを構造中心に
持つ液晶性化合物、さらにはサーモトロピック液晶性と
同時にこのようなリオトロピック液晶性も同時に満たす
液晶性化合物が切望されてきた。
Therefore, a liquid crystal compound having a calixarene at the center of its structure, and further a liquid crystal compound satisfying both the thermotropic liquid crystal property and the lyotropic liquid crystal property at the same time have been earnestly desired.

【0007】[0007]

【課題を解決するための手段】本発明者らは、上述した
如き課題に鑑みて鋭意研究を重ねた結果、図1に示す、
カリックスアレーンを分子コアに持ち(R = CnH2n+1
nは5〜23の整数)、コーン型の分子形状を有する新
規の液晶性化合物を見出した。該液晶性化合物はカリッ
クスアレーン部とアルキル長鎖を持つフェニル基とをC
≡C三重結合で繋いでいるが、このような構造をもつカ
リックスアレーン液晶性化合物については未だ報告がな
く、本発明者らにより今回初めて見出されたものであ
る。
The inventors of the present invention have conducted extensive studies in view of the above-mentioned problems, and as a result, the results are shown in FIG.
Having a calixarene in the molecular core (R = C n H 2n + 1 ;
n is an integer of 5 to 23), and a new liquid crystal compound having a cone-shaped molecular shape was found. The liquid crystalline compound has a calixarene part and a phenyl group having an alkyl long chain as C
A calixarene liquid crystal compound having such a structure, which is connected by a ≡C triple bond, has not been reported yet, and was first discovered by the present inventors.

【0008】また、該新規液晶性化合物が温度依存型
(サーモトロピック)及び濃度依存型(リオトロピッ
ク)液晶性の両液晶性を示すことが見出された。
It has also been found that the novel liquid crystalline compounds exhibit both temperature-dependent (thermotropic) and concentration-dependent (lyotropic) liquid crystallinity.

【0009】さらに、発現するカラムナー相において分
子がキャップを重ねたような積層状態にあることから、
該液晶性化合物がカラム液晶相を持つことを見出し、こ
こに本発明を完成するに至った。
Further, since the molecules are in a laminated state such that caps are stacked in the columnar phase which develops,
The inventors have found that the liquid crystalline compound has a column liquid crystal phase, and have completed the present invention.

【0010】本発明は、下記に示す通りの新規カリック
スアレーン誘導体に関する。 項1.化学式(1);
The present invention relates to novel calixarene derivatives as shown below. Item 1. Chemical formula (1);

【0011】[0011]

【化2】 [Chemical 2]

【0012】(式中、R = CnH2n+1;nは5〜23の整
数)で表わされる化学構造を有することを特徴とする液
晶性化合物。 項2.サーモトロピック液晶性及びリオトロピック液晶
性を持つことを特徴とする、請求項1に記載の液晶性化
合物。 項3.カラム構造を持つ液晶相を有することを特徴とす
る、請求項1又は2に記載の液晶性化合物。 項4.Rが炭素数5〜23のアルキル鎖であることを特
徴とする、請求項1〜3のいずれかに記載の液晶性化合
物。
A liquid crystalline compound having a chemical structure represented by the formula (wherein R = C n H 2n + 1 ; n is an integer of 5 to 23). Item 2. The liquid crystalline compound according to claim 1, which has a thermotropic liquid crystalline property and a lyotropic liquid crystalline property. Item 3. The liquid crystalline compound according to claim 1, which has a liquid crystal phase having a column structure. Item 4. The liquid crystalline compound according to claim 1, wherein R is an alkyl chain having 5 to 23 carbon atoms.

【0013】[0013]

【発明の実施の形態】本発明の化合物は、一般式(1)BEST MODE FOR CARRYING OUT THE INVENTION The compound of the present invention has the general formula (1):

【0014】[0014]

【化3】 [Chemical 3]

【0015】(式中、R = CnH2n+1;nは5〜23の整
数)で表わされるように、カリックスアレーンを分子コ
アにもち、コーン型の分子形状を有する。
As shown by the formula (R = C n H 2n + 1 ; n is an integer of 5 to 23), it has a calixarene in the molecular core and has a cone-shaped molecular shape.

【0016】上記一般式中のRは、同一又は異なって、R
= CnH2n+1(nは5〜23の整数)であるアルキル基で
ある。
R in the above general formula is the same or different and
= C n H 2n + 1 (n is an integer of 5 to 23).

【0017】これらアルキル基の炭素数としては、該化
合物の液晶性を保持する目的から、炭素数5〜23、好
ましくは炭素数10〜23、より好ましくは炭素数12
〜16が挙げられる。
The number of carbon atoms of these alkyl groups is 5 to 23 carbon atoms, preferably 10 to 23 carbon atoms, and more preferably 12 carbon atoms for the purpose of maintaining the liquid crystallinity of the compound.
-16 are mentioned.

【0018】例えば、図2に示すように、本発明の液晶
性化合物は、発現するカラムナー相において分子がキャ
ップを重ねたような積層状態にあることから、カラム液
晶相を持つことが示される(M+;金属陽イオンを表わ
す)。
For example, as shown in FIG. 2, the liquid crystal compound of the present invention has a column liquid crystal phase because the molecules are in a laminated state such that the caps are overlapped in the columnar phase that develops ( M +: represents a metal cation).

【0019】本発明の液晶性化合物は、温度変化に伴う
相転移の結果液晶状態をとる、温度依存型(サーモトロ
ピック)液晶性を示す。加えて、ヘキサンやアセトンと
いった通常の有機溶媒存在下、室温、ある濃度範囲で液
晶となる濃度依存型(リオトロピック)液晶性を示す。
これらサーモトロピック及びリオトロピックの両液晶性
をもつ化合物については、今までに知られていない。
The liquid crystalline compound of the present invention exhibits a temperature-dependent (thermotropic) liquid crystallinity which takes a liquid crystal state as a result of a phase transition accompanying a temperature change. In addition, it exhibits a concentration-dependent (lyotropic) liquid crystallinity that becomes a liquid crystal at room temperature in a certain concentration range in the presence of an ordinary organic solvent such as hexane or acetone.
The compounds having both thermotropic and lyotropic liquid crystallinity have not been known so far.

【0020】さらに、この化合物が示す液晶相は全てコ
ーン型分子が積層してできるカラム構造を有しており、
カラム構造体の電場等外部場に対する応答を利用した電
気特性のスイッチング機能など光・電子物性の一機能発
現形態に深く係わるほか、カラム構造に由来する高い電
荷移動効率、多様な光導波制御性等の各種物性が、今後
の新たな液晶材料応用への道を開き得る。
Further, the liquid crystal phase represented by this compound has a column structure formed by stacking cone type molecules,
In addition to being deeply involved in the expression of one function of optical and electronic properties such as the switching function of electrical characteristics using the response of the column structure to an external field such as an electric field, high charge transfer efficiency derived from the column structure, various optical waveguide controllability, etc. The various physical properties of p can open the way for new applications of liquid crystal materials in the future.

【0021】[0021]

【実施例】以下、本発明の内容を実施例を用いてより具
体的に説明するが、本発明はこれらに何ら限定されるも
のではない。
EXAMPLES The contents of the present invention will be described more specifically below with reference to examples, but the present invention is not limited thereto.

【0022】実施例1 ヘキサデシロキシ誘導体(C16)の合成 (1)p−テトラ−tert−ブチルテトラヒドロキシ
カリックス[4]アレーンの合成 ホルムアルデヒド(37%水溶液)21ml、p−te
rt−ブチルフェノール33g及び水酸化ナトリウム
0.6gを110〜120℃で2時間加熱した。反応物
を室温で放冷したのち、ジフェニルエーテル100ml
に溶解させた。これに窒素ガスを流しながら環流温度ま
で加熱した後、2時間245℃で加熱環流させた。室温
まで放冷した後、酢酸エチル150mlを加えて固体を
沈殿させた。このまま14時間放置した後、吸引濾過し
て沈殿物を濾別した。固体は酢酸エチルで2回洗浄し、
酢酸で1回、水で2回洗浄した。沸騰させたトルエン5
00mlに該固体を溶解させた後、溶媒量を半分に留去
して放冷すると白色結晶が析出した。該白色結晶を濾過
した後、乾燥させ、15gの目的物を得た。
Example 1 Synthesis of hexadecyloxy derivative (C16) (1) Synthesis of p-tetra-tert-butyltetrahydroxycalix [4] arene 21 ml of formaldehyde (37% aqueous solution), p-te
33 g of rt-butylphenol and 0.6 g of sodium hydroxide were heated at 110-120 ° C. for 2 hours. After allowing the reaction product to cool at room temperature, 100 ml of diphenyl ether
Dissolved in. The mixture was heated to the reflux temperature while flowing nitrogen gas, and then refluxed by heating at 245 ° C. for 2 hours. After allowing to cool to room temperature, 150 ml of ethyl acetate was added to precipitate a solid. After leaving it as such for 14 hours, suction filtration was performed to separate the precipitate. The solid was washed twice with ethyl acetate,
It was washed once with acetic acid and twice with water. Boiled toluene 5
After dissolving the solid in 00 ml, the solvent amount was distilled in half and the mixture was allowed to cool to precipitate white crystals. The white crystals were filtered and dried to obtain 15 g of the desired product.

【0023】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 9.6(s, 4
H, ArOH), 7.17(s, 8H, ArH), 4.30(br d, 4H, Ar-C
H 2), 3.55(br d, 4H, Ar-CH 2), 1.26(s, 36H, -C(C
H 3)3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 9.6 (s, 4
H, ArO H ), 7.17 (s, 8H, Ar H ), 4.30 (br d, 4H, Ar-C
H 2 ), 3.55 (br d, 4H, Ar-C H 2 ), 1.26 (s, 36H, -C (C
H 3) 3).

【0024】(2)テトラヒドロキシカリックス[4]
アレーンの合成 前項(1)で合成したカリックスアレーン6.65g、
塩化アルミニウム7g及びフェノール4.5gをトルエ
ン60mlに溶解させ、室温で1時間撹拌した。反応混
合物に濃塩酸125mlを加えて反応を終了させた後、
生成物をトルエンで抽出した。溶媒をある程度留去した
後、メタノール20mlを加えて沈殿した白色固体を濾
別した。クロロホルムとメタノールの混合液から再結晶
させ、3gの目的物を得た。
(2) Tetrahydroxycalix [4]
6.65 g of calixarene synthesized in the above (1),
7 g of aluminum chloride and 4.5 g of phenol were dissolved in 60 ml of toluene and stirred at room temperature for 1 hour. After adding 125 ml of concentrated hydrochloric acid to the reaction mixture to terminate the reaction,
The product was extracted with toluene. After distilling off the solvent to some extent, 20 ml of methanol was added and the precipitated white solid was filtered off. Recrystallization from a mixed solution of chloroform and methanol gave 3 g of the desired product.

【0025】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 10.2(s, 4
H, ArOH), 7.04(d, 8H, ArH), 6.72(t, 4H, ArH), 4.26
(brd, 4H, Ar-CH 2), 3.51(br d, 4H, Ar-CH 2)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 10.2 (s, 4
H, ArO H ), 7.04 (d, 8H, Ar H ), 6.72 (t, 4H, Ar H ), 4.26
(brd, 4H, Ar-C H 2 ), 3.51 (br d, 4H, Ar-C H 2 ).

【0026】(3)コーン型テトラプロポキシカリック
ス[4]アレーンの合成 前項(2)で合成したカリックスアレーン2.3gをジ
メチルホルムアミド50mlに融解させた後、窒素ガス
気流下、撹拌しながらゆっくりとこれに水素化ナトリウ
ム2.4gを加えた。5分間撹拌した後、臭化プロピル
8gを加え、室温で一晩撹拌した。まずメタノールを、
次に水を加えて、過剰の水素化ナトリウムを処理した。
反応混合物を濾過した後、シリカゲルのカラムをヘキサ
ンと塩化メチレンの混合溶液によって流し出すことによ
り、得られた固体を精製した。この結果、1.4gの白
色結晶を得た。
(3) Synthesis of corn-type tetrapropoxycalix [4] arene 2.3 g of calixarene synthesized in the above (2) was melted in 50 ml of dimethylformamide and then slowly stirred under a nitrogen gas stream with stirring. To the mixture was added 2.4 g of sodium hydride. After stirring for 5 minutes, 8 g of propyl bromide was added, and the mixture was stirred overnight at room temperature. First, methanol
Excess sodium hydride was then treated by adding water.
After filtering the reaction mixture, the solid obtained was purified by flushing a column of silica gel with a mixed solution of hexane and methylene chloride. As a result, 1.4 g of white crystals were obtained.

【0027】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 6.57(s, 8
H, ArH), 4.44(d, 4H, Ar-CH 2), 3.84(t, 8H, Ar-O-CH 2
-R), 3.14(d, 4H, Ar-CH 2), 1.91(hextet, 8H, Ar-O-CH
2-CH 2-CH3), 0.98(t, 12H,Ar-O-CH2-CH2-CH 3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 6.57 (s, 8
H, Ar H ), 4.44 (d, 4H, Ar-C H 2 ), 3.84 (t, 8H, Ar-OC H 2
-R), 3.14 (d, 4H, Ar-C H 2 ), 1.91 (hextet, 8H, Ar-O-CH
2 -C H 2 -CH 3 ), 0.98 (t, 12H, Ar-O-CH 2 -CH 2 -C H 3 ).

【0028】(4)テトラ−p−ヨウ化テトラプロポキ
シカリックス[4]アレーンの合成 前項(3)で合成した化合物0.7gを乾燥させた後、
蒸留した直後のクロロホルム100mlに融解させ、さ
らに窒素気流下で撹拌しながらトリフルオロ酢酸銀1.
35gを加えた。これを20分間加熱環流した後、ヨウ
素1.58gを加え、さらに1時間環流した。反応混合
物を熱濾過し、濾液を放冷した後、メタ亜硫酸ナトリウ
ムの飽和水溶液で洗浄した。有機層を水で洗浄して乾燥
させた後、溶媒を留去した。シリカゲルカラムをヘキサ
ンと塩化メチレンの混合液で流して目的物を精製した
後、最後にクロロホルムとメタノールの混合溶媒からこ
れを再結晶し、0.97gを得た。
(4) Synthesis of tetra-p-iodinated tetrapropoxycalix [4] arene After drying 0.7 g of the compound synthesized in the above (3),
Immediately after the distillation, it was melted in 100 ml of chloroform and further stirred under a nitrogen stream while stirring silver trifluoroacetate 1.
35 g was added. This was refluxed for 20 minutes, 1.58 g of iodine was added, and the reflux was continued for another 1 hour. The reaction mixture was hot filtered, the filtrate was allowed to cool and then washed with a saturated aqueous solution of sodium metabisulfite. The organic layer was washed with water and dried, and then the solvent was distilled off. After purifying the target product by passing it through a silica gel column with a mixed solution of hexane and methylene chloride, the product was finally recrystallized from a mixed solvent of chloroform and methanol to obtain 0.97 g.

【0029】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 6.99(s, 8
H, ArH), 4.29(d, 4H, Ar-CH 2), 3.80(t, 8H, Ar-O-CH 2
-R), 3.05(d, 4H, Ar-CH 2), 1.85(hextet, 8H, Ar-O-CH
2-CH 2-CH3), 0.95(t, 12H,Ar-O-CH2-CH2-CH 3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 6.99 (s, 8
H, Ar H ), 4.29 (d, 4H, Ar-C H 2 ), 3.80 (t, 8H, Ar-OC H 2
-R), 3.05 (d, 4H, Ar-C H 2 ), 1.85 (hextet, 8H, Ar-O-CH
2 -C H 2 -CH 3 ), 0.95 (t, 12H, Ar-O-CH 2 -CH 2 -C H 3 ).

【0030】(5)p−ヘキサデシロキシベンズアルデ
ヒドの合成 1−臭化ヘキサデカン5.2g、p−ヒドロキシベンズ
アルデヒド2g及び炭酸カリウム5.8gをアセトン1
00mlに融解させ、一晩加熱環流した。得られた固体
を濾別した後、これを温アセトンで洗浄して濾液に加え
てから、溶媒のアセトンを留去した。シリカゲルカラム
中を塩化メチレンで流して残査を精製し、3gの目的物
を得た。
(5) Synthesis of p-hexadecyloxybenzaldehyde 5.2 g of 1-hexadecane bromide, 2 g of p-hydroxybenzaldehyde and 5.8 g of potassium carbonate were added to acetone 1
It was thawed to 00 ml and heated to reflux overnight. The obtained solid was filtered off, washed with warm acetone and added to the filtrate, and then the solvent acetone was distilled off. The residue was purified by flowing through a silica gel column with methylene chloride to obtain 3 g of the desired product.

【0031】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 9.89(s, 1
H, Ar-CHO), 7.82(d, 2H, ArH), 6.98(d, 2H, ArH), 4.
04(t, 2H, -OCH 2), 1.81(m, 2H, -OCH2CH 2), 1.5〜1.3
(m, 26H, -CH 2-), 0.88(t, 3H, -CH 3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 9.89 (s, 1
H, Ar-C H O), 7.82 (d, 2H, Ar H ), 6.98 (d, 2H, Ar H ), 4.
04 (t, 2H, -OC H 2 ), 1.81 (m, 2H, -OCH 2 C H 2 ), 1.5 ~ 1.3
(m, 26H, -C H 2- ), 0.88 (t, 3H, -C H 3 ).

【0032】(6)p−ヘキサデシロキシベンジルアセ
チレンの合成 蒸留した直後のテトラヒドロフラン75mlにカリウム
ブトキシド2gを溶解させた後、−78℃で臭化トリフ
ェニルホスフィニウム臭化メチレン3gを加えた。これ
を5分間撹拌した後、前項(5)で合成したアルデヒド
2.4gをテトラヒドロフラン50mlに溶解した溶液
を、該溶液に滴下した。反応混合物を室温で放温したま
ま、窒素気流下で一晩撹拌した。これに水30mlを加
えて有機相をヘキサンで抽出した後、無水硫酸マグネシ
ウムで乾燥した。溶媒を留去した後、得られた個体をヘ
キサン及び塩化メチレン混合溶媒を用いてシリカゲルカ
ラムにより精製し、1.5gの目的物を得た。
(6) Synthesis of p-hexadecyloxybenzylacetylene After dissolving 2 g of potassium butoxide in 75 ml of tetrahydrofuran immediately after distillation, 3 g of triphenylphosphinium bromide bromide was added at -78 ° C. After stirring this for 5 minutes, a solution prepared by dissolving 2.4 g of the aldehyde synthesized in the above (5) in 50 ml of tetrahydrofuran was added dropwise to the solution. The reaction mixture was allowed to stand at room temperature and stirred overnight under a nitrogen stream. 30 ml of water was added thereto, the organic phase was extracted with hexane, and then dried over anhydrous magnesium sulfate. After evaporating the solvent, the obtained solid was purified by a silica gel column using a mixed solvent of hexane and methylene chloride to obtain 1.5 g of the desired product.

【0033】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 9.89(s, 1
H, Ar-CHO), 7.41(d, 2H, ArH), 6.82(d, 2H, ArH), 3.
94(t, 2H, -OCH 2),2.98(s, 1H, C≡C−H), 1.77(m, 2H,
-OCH2CH 2), 1.5〜1.3(m, 26H, -CH 2-), 0.88(t, 3H, -
CH 3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 9.89 (s, 1
H, Ar-C H O), 7.41 (d, 2H, Ar H ), 6.82 (d, 2H, Ar H ), 3.
94 (t, 2H, -OC H 2 ), 2.98 (s, 1H, C≡C− H ), 1.77 (m, 2H,
-OCH 2 C H 2 ), 1.5 to 1.3 (m, 26H, -C H 2- ), 0.88 (t, 3H,-
C H 3 ).

【0034】(7)テトラ−p−(p−ヘキサデシロキ
シベンジルアセチレン)テトラ−p−プロポキシカリッ
クス[4]アレーンの合成 前項(6)で合成したベンジルアセチレン0.52gと
(4)で合成したカリックスアレーン0.2gをトリプ
ロピルアミン40mlに溶解させ、吸引して気体を抜い
た。テトラトリフェニルホスフィンパラジウム及びヨウ
化銅を触媒量加え、50℃で2時間半撹拌した。氷浴で
冷却し反応を終了させた後、濃塩酸200mlを加え
た。溶液を酢酸エチルで抽出し、得られた有機相を硫酸
マグネシウムで乾燥後、溶媒を留去した。塩化メチレ
ン、ヘキサン混合溶媒を用いて、得られた固体をシリカ
ゲルカラムで精製した。単離した固体を再びアセトンか
ら再結晶して0.28gの目的物を得た。
(7) Synthesis of tetra-p- (p-hexadecyloxybenzylacetylene) tetra-p-propoxycalix [4] arene 0.52 g of benzylacetylene synthesized in the above (6) and (4) were synthesized. 0.2 g of calixarene was dissolved in 40 ml of tripropylamine and suctioned to remove the gas. Tetratriphenylphosphine palladium and copper iodide were added in catalytic amounts, and the mixture was stirred at 50 ° C. for 2 hours and a half. After cooling with an ice bath to terminate the reaction, 200 ml of concentrated hydrochloric acid was added. The solution was extracted with ethyl acetate, the obtained organic phase was dried over magnesium sulfate, and then the solvent was distilled off. The obtained solid was purified with a silica gel column using a mixed solvent of methylene chloride and hexane. The isolated solid was recrystallized from acetone again to obtain 0.28 g of the desired product.

【0035】得られた物質の1H NMR (CDCl3)分析結果は
以下の通りである。1H NMR (CDCl3)σ(ppm): 7.32(d, 8
H, J = 8.5, ArH) 6.92(s, 8H, ArH), 6.67(d, 8H, J =
8.5, ArH), 4.29(d, 4H, J = 13.5, Ar-CH 2), 3.89(t,
16H, J = 7, Ar-O-CH 2-R),3.15(d, 4H, J = 13.5, Ar-
CH 2), 1.92(hextet, 8H, J = 7.7, Ar-O-CH2-CH 2-CH3),
1.75(hextet, 8H, J = 7.7, Ar-O-CH2-CH 2-R), 1.25
(m, 92H, CH2(CH 2)13CH3), 0.99(t, 12H, J = 7, Ar-O-
CH2-CH2-CH 3), 0.87(t, 12H, J = 7.5, R-CH 3)。
The results of 1 H NMR (CDCl 3 ) analysis of the obtained substance are as follows. 1 H NMR (CDCl 3 ) σ (ppm): 7.32 (d, 8
H, J = 8.5, Ar H ) 6.92 (s, 8H, Ar H ), 6.67 (d, 8H, J =
8.5, Ar H ), 4.29 (d, 4H, J = 13.5, Ar-C H 2 ), 3.89 (t,
16H, J = 7, Ar-OC H 2 -R), 3.15 (d, 4H, J = 13.5, Ar-
C H 2 ), 1.92 (hextet, 8H, J = 7.7, Ar-O-CH 2 -C H 2 -CH 3 ),
1.75 (hextet, 8H, J = 7.7, Ar-O-CH 2 -C H 2 -R), 1.25
(m, 92H, CH 2 (C H 2 ) 13 CH 3 ), 0.99 (t, 12H, J = 7, Ar-O-
CH 2 -CH 2 -C H 3 ), 0.87 (t, 12H, J = 7.5, RC H 3 ).

【0036】ここで得られた物質について元素分析を行
った結果、測定値(%)[理論値(%)]: C 83.45
[83.54]、H 10.10[9.92]との結果が得られた。これ
らの値から、得られた化合物の分子構造が目的物である
テトラ−p−(p−ヘキサデシロキシベンジルアセチレ
ン)テトラ−p−プロポキシカリックス[4]アレーンと
一致することがわかり、該物質の合成が確認された。
As a result of elemental analysis of the substance obtained here, measured value (%) [theoretical value (%)]: C 83.45
[83.54] and H 10.10 [9.92] were obtained. From these values, it was found that the molecular structure of the obtained compound was in agreement with the target compound, tetra-p- (p-hexadecyloxybenzylacetylene) tetra-p-propoxycalix [4] arene, Synthesis was confirmed.

【0037】実施例2 ドデシルオキシ誘導体(C12)の合成 テトラ−p−(p−ドデシルオキシベンジルアセチレ
ン)テトラ−p−プロポキシカリックス[4]アレーンの
合成 実施例1の(5)及び(6)と同様の方法でヘキサデシ
ロキシ誘導体の代わりにドデシルオキシ誘導体を用い、
ベンジルアセチレン誘導体を合成した。得られたベンジ
ルアセチレン誘導体を、上記(7)と同様の方法で上記
(4)で合成したカリックスアレーンと反応させ、目的
とする化合物を得た。
Example 2 Synthesis of dodecyloxy derivative (C12) Synthesis of tetra-p- (p-dodecyloxybenzylacetylene) tetra-p-propoxycalix [4] arene (5) and (6) of Example 1 In the same manner, using a dodecyloxy derivative instead of the hexadecyloxy derivative,
A benzylacetylene derivative was synthesized. The obtained benzylacetylene derivative was reacted with the calixarene synthesized in (4) above in the same manner as in (7) above to obtain the desired compound.

【0038】実施例3 液晶性の検討 DSC測定、X線回折測定ならびに温度制御装置付き偏
光顕微鏡による液晶組織観察により、実施例1で得られ
た化合物C12H25及び実施例2で得られた化合物C16H33
関して、液晶性の検討を行った。
Example 3 Investigation of liquid crystallinity The compounds C 12 H 25 obtained in Example 1 and Example 2 were obtained by DSC measurement, X-ray diffraction measurement and liquid crystal texture observation by a polarization microscope equipped with a temperature controller. The liquid crystallinity of the compound C 16 H 33 was examined.

【0039】表1に、各化合物のサーモトロピック液晶
性(相転移温度及び現れる液晶相)を示す。
Table 1 shows the thermotropic liquid crystallinity (phase transition temperature and emerging liquid crystal phase) of each compound.

【0040】[0040]

【表1】 [Table 1]

【0041】表2に、各化合物のリオトロピック液晶性
(溶媒及び現れる液晶相)を示す。
Table 2 shows the lyotropic liquid crystallinity (solvent and emerging liquid crystal phase) of each compound.

【0042】[0042]

【表2】 [Table 2]

【0043】以上より、本発明に従いアルキル鎖長を換
えて合成した2種類の化合物が、同様の液晶性を持つこ
とが判った。
From the above, it was found that the two kinds of compounds synthesized by changing the alkyl chain length according to the present invention have similar liquid crystallinity.

【0044】[0044]

【発明の効果】本発明の化合物が示す液晶相は全て、コ
ーン型分子が積層してできるカラム構造を有しているこ
とから、電気特性スイッチ機能など光電子物性の一機能
発現形態に深く係わり、今後の新たな液晶材料に応用で
きる。
Since the liquid crystal phase of the compound of the present invention has a column structure formed by stacking cone-shaped molecules, it is deeply involved in a form of expressing one function of optoelectronic properties such as a function of switching electrical characteristics, It can be applied to new liquid crystal materials in the future.

【0045】また、本発明の液晶性化合物の特徴は、反
平行カラム配向をもつことにある。この特徴と、液晶性
という自己組織化性を利用して、電子やホール、イオン
等の電荷担体の移動パスを分子サイズ(ナノサイズ)で
構築可能である。
The characteristic feature of the liquid crystal compound of the present invention is that it has antiparallel column alignment. By utilizing this characteristic and the self-organizing property of liquid crystallinity, it is possible to construct a migration path of charge carriers such as electrons, holes, and ions in a molecular size (nano size).

【0046】従って、本発明の化合物は、光・電子変
換、電子写真感光体特性、電荷輸送性などの電子・光機
能を有するナノ構造を有する各種電子材料、デバイス技
術として利用できる。
Therefore, the compound of the present invention can be utilized as various electronic materials having a nanostructure having an electronic / optical function such as photo-electron conversion, electrophotographic photoreceptor characteristics, charge transportability, and device technology.

【0047】リオトロピック液晶相は、一般的にサーモ
トロピック液晶相に比べて粘性が低いため、本発明の化
合物は、その分、電場などの微弱外部場による分子配向
の制御が容易である。従って、サーモトロピック液晶性
及びリオトロピック液晶性の両性質を併せもつ本発明の
化合物を用いて薄膜を作製し、しかもその膜中で分子
(或いはカラム)がある一方向に配向する必要性がある
場合には、有利な条件での配向膜作製が可能となる。
Since the lyotropic liquid crystal phase generally has a lower viscosity than the thermotropic liquid crystal phase, the compound of the present invention can easily control the molecular orientation by a weak external field such as an electric field. Therefore, when it is necessary to prepare a thin film by using the compound of the present invention having both the thermotropic liquid crystallinity and the lyotropic liquid crystallinity and further to align the molecules (or columns) in one direction in the film. In addition, it is possible to fabricate the alignment film under advantageous conditions.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は、本発明の液晶性化合物を示す。FIG. 1 shows a liquid crystal compound of the present invention.

【図2】図2は、図1に示したコーン型分子の積層カラ
ム構造とその配列を示す。
FIG. 2 shows a stacked column structure of the cone-shaped molecule shown in FIG. 1 and its arrangement.

フロントページの続き (72)発明者 ジャービス ヘレン 大阪府池田市緑丘1丁目8番31号 独立行 政法人産業技術総合研究所関西センター内 Fターム(参考) 4H006 AA01 AB64 GP03 Continued front page    (72) Inventor Jarvis Helen             1-83-1 Midorigaoka, Ikeda, Osaka Prefecture             AIST Kansai Center F-term (reference) 4H006 AA01 AB64 GP03

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】化学式(1); 【化1】 (式中、R = CnH2n+1;nは5〜23の整数)で表わさ
れる化学構造を有することを特徴とする液晶性化合物。
1. A chemical formula (1); (Wherein, R = C n H 2n + 1; n is an integer of 5-23) liquid crystal compound characterized by having a chemical structure represented by.
【請求項2】サーモトロピック液晶性及びリオトロピッ
ク液晶性を持つことを特徴とする、請求項1に記載の液
晶性化合物。
2. The liquid crystalline compound according to claim 1, which has a thermotropic liquid crystalline property and a lyotropic liquid crystalline property.
【請求項3】カラム構造を持つ液晶相を有することを特
徴とする、請求項1又は2に記載の液晶性化合物。
3. The liquid crystal compound according to claim 1, having a liquid crystal phase having a column structure.
【請求項4】Rが炭素数5〜23のアルキル鎖であるこ
とを特徴とする、請求項1〜3のいずれかに記載の液晶
性化合物。
4. The liquid crystal compound according to claim 1, wherein R is an alkyl chain having 5 to 23 carbon atoms.
JP2001289723A 2001-09-21 2001-09-21 Cyclic liquid crystalline composition Expired - Lifetime JP3849009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001289723A JP3849009B2 (en) 2001-09-21 2001-09-21 Cyclic liquid crystalline composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001289723A JP3849009B2 (en) 2001-09-21 2001-09-21 Cyclic liquid crystalline composition

Publications (2)

Publication Number Publication Date
JP2003096015A true JP2003096015A (en) 2003-04-03
JP3849009B2 JP3849009B2 (en) 2006-11-22

Family

ID=19112174

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001289723A Expired - Lifetime JP3849009B2 (en) 2001-09-21 2001-09-21 Cyclic liquid crystalline composition

Country Status (1)

Country Link
JP (1) JP3849009B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111108177A (en) * 2017-10-05 2020-05-05 Dic株式会社 Liquid crystal composition and liquid crystal display element

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111108177A (en) * 2017-10-05 2020-05-05 Dic株式会社 Liquid crystal composition and liquid crystal display element
CN111108177B (en) * 2017-10-05 2023-06-20 Dic株式会社 Liquid crystal composition and liquid crystal display element

Also Published As

Publication number Publication date
JP3849009B2 (en) 2006-11-22

Similar Documents

Publication Publication Date Title
JP5940548B2 (en) Novel spirobifluorene compounds
TW201420581A (en) Method for producing aromatic compound
CN108251128B (en) Liquid crystal compound with negative dielectric anisotropy and preparation method and application thereof
JP5515069B2 (en) Perylenetetracarboxylic acid bisimide derivative, n-type semiconductor, method for producing n-type semiconductor, and electronic device
JP4099526B2 (en) Separation and purification of porphyrin dimer derivatives and carbon nanotubes using them
JP2012169550A (en) Organic semiconductor material
JP3849009B2 (en) Cyclic liquid crystalline composition
CN113717056B (en) Compound and application thereof
JP5219186B2 (en) Highly soluble pentacene compound and organic semiconductor device using the same
CN114507237A (en) Aza-polycyclic fused ring compound based on diacenaphthopyrazinooxaline and synthetic method
JP5888815B2 (en) Method for synthesizing anti-ant radical kogenophene
CN112409325A (en) Synthesis and luminescence of bis-benzophenanthrene thiophene discotic liquid crystal compound
JP2012236777A (en) Indolocarbazole-containing imide compound, and intermediate for synthesizing the same, method for producing them, organic semiconductor composition, and organic solar cell element
JP4210753B2 (en) Metal complex dendrimer and its use
JPS6163631A (en) Amphoteric compound
US5175280A (en) Thia-and/or selenafulvalenyl group-containing compound
CN111253366B (en) Phenyl benzothiophene rod-shaped liquid crystal compound and preparation method thereof
JP3712037B2 (en) Cyclic compounds and organic electroluminescent materials
JP2014005220A (en) Tetrabenzotetracene derivative, method for synthesis of the same, and use of the same
CN109020969B (en) Imidazole derivative and preparation method and application thereof
JP2009049056A (en) Field-effect transistor using hexabenzocoronene nanotube
JP7133750B2 (en) Iodine-containing condensed ring compound and organic electronic material using iodine-containing condensed ring compound
CN105016988A (en) Polyalkyloxy substituted 1,2-benzochrysene derivative and preparation method therefor
JPH0327549B2 (en)
CN115304643A (en) Organic metal compound and application thereof

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060801

R150 Certificate of patent or registration of utility model

Ref document number: 3849009

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term